Access
To read this story in full you will need to login or make a payment (see right).
Letters to Nature
Nature 366, 748-751 (30 December 1993) | doi:10.1038/366748a0; Accepted 25 October 1993
Potential virulence determinants in terminal regions of variola smallpox virus genome
Robert F. Massung*, Joseph J. Esposito*†, Li-ing Liu‡§, Jin Qi*, Theresa R. Utterback‡§, Janice C. Knight*, Lisa Aubin‡§, Thomas E. Yuran*, Joseph M. Parsons*, Vladimir N. Loparev*, Nickolay A. Selivanov‡, Kathleen F. Cavallaro*, Anthony R. Kerlavage‡§, Brian W. J. Mahy* & J. Craig Venter‡§
- *Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
- ‡National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892, USA
- §The Institute for Genomic Research, Gaithersburg, Maryland 20878, USA
- †To whom correspondence should be addressed.
Abstract
SMALLPOX eradication culminated the most successful antimicrobial campaign in medical history1. To characterize further the linear double-stranded DNA genome of the aetiological agent of smallpox, we have determined the entire nucleotide sequence of the highly virulent variola major virus, strain Bangladesh-1975 (VAR-BSH; 186,102 base pairs, 33.7% G + C; Genbank accession number, L22579). Here we highlight features of the molecule and focus on a few of the 187 putative proteins that probably contribute to pathogenicity and virus host-range properties. One hundred and fifty proteins were markedly similar to those of vaccinia virus (smallpox vaccine), for which a complete sequence has been reported2,3 for strain Copenhagen (VAC-CPN; 191,636 base pairs, 33.3% G + C). The remaining 37 proteins reflected variola-specific sequences or open reading frame divergences for variant proteins, which are often truncated or elongated compared with their vaccinia counterparts.
To read this story in full you will need to login or make a payment (see right).
